Wearable Injectors Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope
Wearable injectors are drug delivery devices that adhere to the body while the drug is administered subcutaneously over a preset time period.

Sizing and Forecast
The wearable injectors market size has grown rapidly in recent years. It will grow from $8.04 billion in 2023 to $9.07 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to chronic disease management, patient convenience, technological advancements, aging population.

The wearable injectors market size is expected to see rapid growth in the next few years. It will grow to $15.23 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include biologics and large molecules, dual-chamber wearables, connected and smart devices, patch pump technology.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/wearable-injectors-global-market-report

Segmentation & Regional Insights
The wearable injectors market covered in this report is segmented –

1) By Type: On-Body Injectors, Off-Body Injectors
2) By End-User: Hospitals, Clinics, Homecare setting
3) By Application: Immuno-Oncology, Diabetes, Cardiovascular Diseases, Other Applications

North America was the largest region in the wearable injectors market in 2023. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3308&type=smp

Major Driver Impacting Market Growth
The rise in the number of diabetic and chronic diseases patients such as cardiovascular diseases and cancers contributed to the growth of the wearable injectors market. According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes, and by 2045, it is estimated that around 783 million adults around the world and 1 in 5 adults who are above 65 are expected to suffer from diabetes. The rise in the number of diabetes and chronic diseases patients increased the demand for the treatment of the diseases, thereby driving the wearable injectors market growth.

Key Industry Players
Major companies operating in the wearable injectors market include Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical plc, United Therapeutics Corporation, Bühler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd, Zosano Pharma Corporation

The wearable injectors market report table of contents includes:

1. Executive Summary

2. Wearable Injectors Market Characteristics

3. Wearable Injectors Market Trends And Strategies

4. Wearable Injectors Market – Macro Economic Scenario

5. Global Wearable Injectors Market Size and Growth

.
.

31. Global Wearable Injectors Market Competitive Benchmarking

32. Global Wearable Injectors Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Wearable Injectors Market

34. Wearable Injectors Market Future Outlook and Potential Analysis

35. Appendix